Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,293 publicly listed stocks with a combined market cap of $2.10 Trillion. Hepion Pharmaceuticals Inc leads the sector with a market cap of $1.66 Million. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$2.10 Trillion
Companies Listed
1,293
Largest Company
Hepion Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1201 |
Hepion Pharmaceuticals Inc
NASDAQ:HEPA |
$1.66 Million | $1.66 Million | USA | $0.06 | -11.97% | -8.09% | 600.68K |
| 1202 |
Jaguar Animal Health Inc
NASDAQ:JAGX |
$1.65 Million | $1.65 Million | USA | $0.32 | +1.59% | -56.30% | 9.49 Million |
| 1203 |
Anatara Lifesciences Ltd
AU:ANR |
$1.57 Million | AU$2.23 Million | Australia | AU$0.01 | +0.00% | -10.00% | 1.99 Million |
| 1204 |
BioSenic S.A.
BR:BIOS |
$1.57 Million | €1.34 Million | Belgium | €0.00 | +0.00% | +0.00% | 3.25 Million |
| 1205 |
Oncternal Therapeutics Inc
NASDAQ:ONCT |
$1.56 Million | $1.56 Million | USA | $0.53 | +0.00% | +0.00% | 0.00 |
| 1206 |
GEMINA LABS LTD
F:8I7 |
$1.53 Million | €1.31 Million | Germany | €0.02 | +0.00% | -16.28% | 4.50K |
| 1207 |
Bone Biologics Corp
NASDAQ:BBLG |
$1.49 Million | $1.49 Million | USA | $0.54 | -2.00% | -1.82% | 16.70 Million |
| 1208 |
Protagenic Therapeutics
NASDAQ:PTIX |
$1.43 Million | $1.43 Million | USA | $0.83 | -4.71% | -17.00% | 510.26K |
| 1209 |
Stayble Therapeutics AB
ST:STABL |
$1.42 Million | Skr13.19 Million | Sweden | Skr0.21 | +0.00% | +0.00% | 148.88 Million |
| 1210 |
ExpreS2ion Biotech Holding AB
ST:EXPRS2 |
$1.41 Million | Skr13.10 Million | Sweden | Skr1.33 | +6.00% | -1.85% | 3.71 Million |
| 1211 |
Appili Therapeutics Inc
TO:APLI |
$1.39 Million | CA$1.93 Million | Canada | CA$0.02 | +50.00% | +0.00% | 1.63 Million |
| 1212 |
Virax Biolabs Group Limited Ordinary Shares
NASDAQ:VRAX |
$1.27 Million | $1.27 Million | USA | $2.59 | -0.77% | -1.33% | 19.48 Million |
| 1213 |
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI |
$1.27 Million | $1.27 Million | USA | $1.54 | -36.89% | -17.20% | 52.03 Million |
| 1214 |
Kezar Life Sciences Inc
NASDAQ:KZR |
$1.26 Million | $1.26 Million | USA | $0.17 | +6.25% | +17.24% | 20.41 Million |
| 1215 |
Biomx Inc
NYSE MKT:PHGE |
$1.25 Million | $1.25 Million | USA | $0.82 | +10.57% | +39.85% | 249.67 Million |
| 1216 |
Scancell Hldgs Plc
LSE:SCLP |
$1.24 Million | GBX10.22 Billion | UK | GBX9.85 | -1.01% | +0.51% | 76.28 Million |
| 1217 |
XTL Biopharmaceuticals Ltd
F:H2K2 |
$1.19 Million | €1.02 Million | Germany | €2.28 | +23.24% | +408.93% | 47.11K |
| 1218 |
2cureX AB
ST:2CUREX |
$1.13 Million | Skr10.54 Million | Sweden | Skr0.42 | -12.13% | -30.00% | 12.95 Million |
| 1219 |
Universal Ibogaine Inc
V:IBO |
$1.13 Million | CA$1.56 Million | Canada | CA$0.01 | +0.00% | +0.00% | 0.00 |
| 1220 |
2CUREX AB SEK-10
F:2QE |
$1.08 Million | €923.79K | Germany | €0.04 | -25.20% | -10.68% | 2.47K |
| 1221 |
PHAXIAM Therapeutics S.A.
PA:PHXM |
$1.01 Million | €863.96K | France | €0.10 | +0.00% | +0.00% | 0.00 |
| 1222 |
Biora Therapeutics Inc
NASDAQ:BIOR |
$994.99K | $994.99K | USA | $0.22 | +0.00% | +0.00% | 0.00 |
| 1223 |
BIOCURE TECHNOLOGY INC.
F:1WH |
$960.84K | €821.86K | Germany | €0.03 | +21.43% | +34.21% | 0.00 |
| 1224 |
Bioventix
LSE:BVXP |
$953.57K | GBX7.84 Billion | UK | GBX1500.00 | -0.66% | -11.76% | 198.47K |
| 1225 |
GeoVax Labs Inc
NASDAQ:GOVX |
$930.57K | $930.57K | USA | $0.42 | -2.72% | -13.37% | 26.76 Million |
| 1226 |
Geneuro SA
PA:GNRO |
$911.56K | €779.71K | France | €0.03 | +0.00% | +0.00% | 0.00 |
| 1227 |
4BASEBIO UK SOCIETAS
LSE:4BB |
$904.35K | GBX7.43 Billion | UK | GBX480.00 | +0.00% | +0.00% | 18.14K |
| 1228 |
ZyVersa Therapeutics Inc.
NASDAQ:ZVSA |
$866.26K | $866.26K | USA | $0.11 | +8.08% | +7.86% | 112.45K |
| 1229 |
Ovoca Gold PLC
IR:OVXA |
$856.42K | €732.54K | Ireland | €0.01 | +0.00% | +0.00% | 0.00 |
| 1230 |
Magle Chemoswed Holding Ab
ST:MAGLE |
$848.88K | Skr7.89 Million | Sweden | Skr0.38 | +0.53% | +9.14% | 493.13K |
| 1231 |
Poolbeg Pharma PLC
LSE:POLB |
$808.13K | GBX6.64 Billion | UK | GBX8.70 | +3.57% | +4.82% | 50.78 Million |
| 1232 |
Enveric Biosciences Inc
NASDAQ:ENVB |
$756.71K | $756.71K | USA | $1.46 | -1.35% | +5.04% | 2.35 Million |
| 1233 |
Integragen
PA:ALINT |
$746.14K | €638.22K | France | €0.10 | -23.33% | -45.88% | 917.61K |
| 1234 |
ALGERNON PHARMACEUT. A
F:AGW0 |
$740.91K | €633.74K | Germany | €0.02 | -2.63% | -43.94% | 9.22K |
| 1235 |
Onconetix Inc
NASDAQ:ONCO |
$730.29K | $730.29K | USA | $0.64 | -15.74% | -5.49% | 12.05 Million |
| 1236 |
Biodexa Pharmaceticals
NASDAQ:BDRX |
$726.11K | $726.11K | USA | $1.12 | -13.85% | +42.68% | 167.85 Million |
| 1237 |
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO |
$716.31K | $716.31K | USA | $0.01 | +30.00% | -18.75% | 10.88 Million |
| 1238 |
Diagonal Bio AB
ST:DIABIO |
$703.53K | Skr6.54 Million | Sweden | Skr0.00 | +0.00% | -20.00% | 217.72 Million |
| 1239 |
Enlivex Therapeutics Ltd
TA:ENLV |
$700.05K | ILA261.12 Million | Israel | ILA1.10 | -18.52% | -83.97% | 6.12 Million |
| 1240 |
Ondine Biomedical Inc
LSE:OBI |
$679.55K | GBX5.59 Billion | UK | GBX10.75 | +4.88% | -4.44% | 19.00 Million |
| 1241 |
IO Biotech Inc
NASDAQ:IOBT |
$611.57K | $611.57K | USA | $0.01 | +3.66% | +150.00% | 11.67 Million |
| 1242 |
Waverley Pharma Inc
V:WAVE |
$585.94K | CA$810.00K | Canada | CA$0.02 | +0.00% | +50.00% | 263.19K |
| 1243 |
PROMIS NEUROSCIENCES
F:23J0 |
$576.86K | €493.42K | Germany | €6.90 | +2.99% | +1849.15% | 243.66K |
| 1244 |
Aptorum Group Ltd Class A
NASDAQ:APM |
$570.06K | $570.06K | USA | $8.32 | -2.92% | +1101.62% | 4.93 Million |
| 1245 |
BRAXIA SCIENTIFIC CORP.
F:4960 |
$566.56K | €484.61K | Germany | €0.00 | +0.00% | +0.00% | 0.00 |
| 1246 |
Sareum Hldgs Plc
LSE:SAR |
$505.78K | GBX4.16 Billion | UK | GBX30.00 | -4.76% | -6.25% | 11.22 Million |
| 1247 |
Faron Pharmaceuticals Oy
LSE:FARN |
$485.05K | GBX3.99 Billion | UK | GBX35.00 | +0.00% | +0.00% | 1.19 Million |
| 1248 |
CELLECTAR NEW22 DL-00001
F:NV4 |
$451.63K | €386.30K | Germany | €0.25 | +0.00% | +0.00% | 0.00 |
| 1249 |
Arecor Therapeutics PLC
LSE:AREC |
$372.10K | GBX3.06 Billion | UK | GBX81.00 | +0.00% | +4.52% | 887.30K |
| 1250 |
ALBERT LABS INTL. CORP.
F:VB50 |
$372.07K | €318.25K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1251 |
Lidds AB
ST:LIDDS |
$361.27K | Skr3.36 Million | Sweden | Skr0.02 | +0.00% | +17.14% | 8.44 Million |
| 1252 |
Lyra Therapeutics Inc
NASDAQ:LYRA |
$337.23K | $337.23K | USA | $0.20 | +0.00% | +0.00% | 26.03K |
| 1253 |
Qlucore AB (publ)
ST:NOVKAN |
$326.04K | Skr3.03 Million | USA | Skr0.03 | -43.95% | -54.46% | 38.54 Million |
| 1254 |
SkinBioTherapeutics PLC
LSE:SBTX |
$307.45K | GBX2.53 Billion | UK | GBX9.75 | +0.00% | +24.20% | 55.90 Million |
| 1255 |
Hemogenyx Pharmaceuticals PLC
LSE:HEMO |
$289.95K | GBX2.38 Billion | UK | GBX444.50 | -1.88% | -11.54% | 627.85K |
| 1256 |
Vaxil Bio Ltd
V:VXL |
$287.36K | CA$397.24K | Canada | CA$0.15 | -3.33% | -17.14% | 72.65K |
| 1257 |
PCI Biotech Holding ASA
OL:PCIB |
$274.95K | Nkr2.61 Million | Norway | Nkr0.07 | -39.13% | -53.95% | 22.88 Million |
| 1258 |
Virpax Pharmaceuticals Inc
NASDAQ:VRPX |
$273.35K | $273.35K | USA | $0.22 | +0.00% | +0.00% | 157.00 |
| 1259 |
Oxurion NV
BR:OXUR |
$248.85K | €212.86K | Belgium | €0.00 | -7.69% | -14.29% | 13.79 Million |
| 1260 |
Chimeric Therapeutics Ltd
AU:CHM |
$220.01K | AU$310.93K | Australia | AU$0.01 | -14.29% | +0.00% | 44.07 Million |
| 1261 |
Kiromic Biopharma Inc
NASDAQ:KRBP |
$214.93K | $214.93K | USA | $22.96 | +1.39% | +1.39% | 35.00 |
| 1262 |
IXICO PLC
LSE:IXI |
$199.82K | GBX1.64 Billion | UK | GBX7.50 | +0.00% | +0.00% | 817.70K |
| 1263 |
ImmuPharma PLC
LSE:IMM |
$196.04K | GBX1.61 Billion | UK | GBX3.21 | -8.43% | -19.88% | 41.90 Million |
| 1264 |
Roquefort Investments PLC
LSE:ROQ |
$184.27K | GBX1.51 Billion | UK | GBX9.25 | +873.68% | +802.44% | 23.80 Million |
| 1265 |
HAVN LIFE SCIENCES INC.
F:5NP0 |
$172.31K | €147.39K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1266 |
Fusion Antibodies PLC
LSE:FAB |
$148.66K | GBX1.22 Billion | UK | GBX10.75 | +16.22% | -6.52% | 11.32 Million |
| 1267 |
QuiaPEG Pharmaceuticals Holding AB
ST:QUIA |
$141.00K | Skr1.31 Million | Sweden | Skr0.00 | -16.67% | -44.44% | 1.38 Billion |
| 1268 |
Biosergen AS
ST:BIOSGN |
$137.73K | Skr1.28 Million | Sweden | Skr0.55 | -54.58% | -57.42% | 13.38 Million |
| 1269 |
Aptamer Group PLC
LSE:APTA |
$111.57K | GBX916.97 Million | UK | GBX0.34 | -9.33% | -9.33% | 266.63 Million |
| 1270 |
CRISM Therapeutics Corporation
LSE:CRTX |
$108.39K | GBX890.83 Million | UK | GBX11.25 | +0.00% | +0.00% | 6.13 Million |
| 1271 |
Scandion Oncology A/S
ST:SCOL |
$103.58K | Skr962.52K | Sweden | Skr0.00 | +0.00% | +0.00% | 29.31 Million |
| 1272 |
Lipigon Pharmaceuticals AB
ST:LPGO |
$97.81K | Skr908.90K | Sweden | Skr0.00 | -44.44% | -61.54% | 559.62 Million |
| 1273 |
NANOSPHERE HEA.SCIENCES
F:2CG |
$90.10K | €77.06K | Germany | €0.01 | +0.00% | +0.00% | 0.00 |
| 1274 |
OptiBiotix Health Plc
LSE:OPTI |
$81.07K | GBX666.29 Million | UK | GBX6.45 | +1.57% | +12.17% | 5.50 Million |
| 1275 |
Cizzle Biotechnology Holdings PLC
LSE:CIZ |
$72.34K | GBX594.59 Million | UK | GBX1.50 | +0.00% | +3.45% | 76.51 Million |
| 1276 |
Vincerx Pharma, Inc. Common Stock
NASDAQ:VINC |
$68.05K | $68.05K | USA | $0.02 | +0.00% | +18.11% | 139.03K |
| 1277 |
Nuformix plc
LSE:NFX |
$49.22K | GBX404.51 Million | UK | GBX0.16 | +0.00% | -3.13% | 719.29 Million |
| 1278 |
Carisma Therapeutics Inc.
NASDAQ:CARM |
$29.29K | $29.29K | USA | $0.00 | +0.00% | -38.46% | 222.73K |
| 1279 |
Physiomics Plc
LSE:PYC |
$28.95K | GBX237.93 Million | UK | GBX0.53 | +0.00% | +1.94% | 82.32 Million |
| 1280 |
BSF Enterprise Plc
LSE:BSFA |
$15.62K | GBX128.37 Million | UK | GBX1.00 | +0.00% | +0.00% | 75.01 Million |
| 1281 |
Futura Medical
LSE:FUM |
$14.04K | GBX115.39 Million | UK | GBX0.20 | -16.60% | -5.48% | 179.48 Million |
| 1282 |
Windtree Therapeutics Inc
NASDAQ:WINT |
$6.74K | $6.74K | USA | $0.00 | -33.33% | +0.00% | 902.35K |
| 1283 |
CannBioRx Life Sciences Corp
NASDAQ:ATNFW |
$4.09K | $4.09K | USA | $0.43 | +0.00% | +0.00% | 1.65 Million |
| 1284 |
Effector Therapeutics Inc
NASDAQ:EFTR |
$940.00 | $940.00 | USA | $0.00 | +0.00% | +0.00% | 132.13K |
| 1285 |
Lipella Pharmaceuticals Inc. Common Stock
NASDAQ:LIPO |
$924.00 | $924.00 | USA | $0.00 | +0.00% | +150.00% | 316.43K |
| 1286 |
Tissue Regenix Group Plc
LSE:TRX |
$628.37 | GBX5.16 Million | UK | GBX0.07 | +0.00% | -99.19% | 22.85 Million |
| 1287 |
Trevena Inc
NASDAQ:TRVN |
$345.52 | $345.52 | USA | $0.00 | -60.00% | -60.00% | 3.32K |
| 1288 |
Lixte Biotechnology Holdings Inc
NASDAQ:LIXTW |
$216.22 | $216.22 | USA | $0.02 | -0.45% | -68.35% | 1.02 Million |
| 1289 |
NLS Pharmaceutics AG
NASDAQ:NLSPW |
$161.49 | $161.49 | USA | $0.02 | -0.56% | +37.69% | 1.50 Million |
| 1290 |
Seelos Therapeutics, Inc.
NASDAQ:SEELQ |
$58.00 | $58.00 | USA | $0.00 | +0.00% | +0.00% | 0.00 |
| 1291 |
Reviva Pharmaceuticals Holdings Inc
NASDAQ:RVPHW |
$28.53 | $28.53 | USA | $0.00 | -16.67% | -69.07% | 3.22 Million |
| 1292 |
Neovacs S.A.
PA:ALNEV |
$14.00 | €11.97 | France | €0.26 | -7.14% | -29.73% | 1.26 Million |
| 1293 |
immatics biotechnologies GmbH
NASDAQ:IMTXW |
$5.77 | $5.77 | USA | $0.00 | +0.00% | +0.00% | 39.12K |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries